Interviews

Dr Fran Gregory Sizes Up the US Adalimumab Market: Will Biosimilars See Success?

September 17th 2023

Podcast

On this episode of Not So Different, Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, analyzes the adalimumab market so far in the United States and provides insight into how the market needs to adapt to accept these products and ensure lower drug costs for patients.

Cardinal Health's Dr Fran Gregory Reacts to First MS Biosimilar Approval

August 27th 2023

Video

Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, shares her reaction to the FDA approval of Tyruko (natalizumab-sztn), the first biosimilar approved to treat multiple sclerosis (MS).

How Streamlining Development Can Save the US Biosimilar Industry

August 20th 2023

Podcast

On this episode of Not So Different, Julie Reed, executive director of the Biosimilars Forum, expanded on ways to make biosimilar development faster and cheaper without compromising on safety and efficacy and how these practices can ensure a sustainable market for the future.

The Top 3 Policy Initiatives That Could Impact the US Biosimilar Market

July 23rd 2023

Video

Julie Reed, MS, executive director of the Biosimilars Forum, takes a look at the 3 policy initiatives that could have the greatest ramifications for the US biosimilars industry.

Julie Reed: When the US Could See Meaningful Savings From Adalimumab, Ranibizumab Biosimilar Competition

June 25th 2023

Video

Juliana (Julie) Reed, executive director of the Biosimilars Forum, predicts how long it will take for savings from adalimumab and ranibizumab biosimilar competition to fully manifest and how stakeholders can champion for better market competition for biosimilars.

Dr Fran Gregory Discusses the Unique Requirements for Handling Biosimilars

June 18th 2023

Video

Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses how specialty pharmacists manage inventory, storage, and handling of biosimilars.

Dr Ryan Haumschild Shares How Oncology Practice, Payer Collaboration Can Increase Biosimilar Adoption

June 18th 2023

Video

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy services at Emory Healthcare and Winship Cancer Institute, explains how oncology practices can work better with payers to increase biosimilar adoption and how those collaborations can be applied to other disease areas, such as immunology and neurology.

Dr Fran Gregory: Providing Patients With High-Quality Biosimilars Is a Collaborative Effort

June 11th 2023

Video

Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses the importance of collaboration between all stakeholders to boost confidence in providing patients with a biosimilar drug.

Dr Fran Gregory Discusses the Future Landscape of the Biosimilars Marketplace

June 7th 2023

Video

Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses what the future biosimilars marketplace may look like compared with generics and reference products at Asembia 2023.

What AmerisourceBergen's Report Reveals About Payers, Biosimilar Pricing Trends

May 28th 2023

Podcast

On this episode of Not So Different, Tasmina Hydery and Brian Biehn from AmerisourceBergen discussed results from a recent survey, that were also presented at Asembia 2023, diving into the payer perspective on biosimilars and current pricing trends across the US biosimilar industry.